Vericel (VCEL) News Today $45.38 -0.01 (-0.02%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$45.38 0.00 (0.00%) As of 07:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Dominick Colangelo Sells 26,592 Shares of Vericel Co. (NASDAQ:VCEL) StockVericel Co. (NASDAQ:VCEL - Get Free Report) CEO Dominick Colangelo sold 26,592 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $45.78, for a total transaction of $1,217,381.76. Following the transaction, the chief executive officer now owns 259,997 shares in the company, valued at $11,902,662.66. This represents a 9.28 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.March 15 at 4:11 PM | marketbeat.comVericel Co. (NASDAQ:VCEL) CEO Sells $1,217,381.76 in StockMarch 15 at 6:42 AM | insidertrades.comRaymond James Financial Inc. Acquires Shares of 512,219 Vericel Co. (NASDAQ:VCEL)Raymond James Financial Inc. acquired a new stake in shares of Vericel Co. (NASDAQ:VCEL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 512,219 shares of the biotechnology company's stock, valued at approximately $28,126,000. RaMarch 15 at 3:42 AM | marketbeat.comVericel Co. (NASDAQ:VCEL) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. cut its stake in Vericel Co. (NASDAQ:VCEL - Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 578,712 shares of the biotechnology company's stock afterMarch 10, 2025 | marketbeat.comStockNews.com Upgrades Vericel (NASDAQ:VCEL) to "Hold"March 10, 2025 | americanbankingnews.comVericel Co. (NASDAQ:VCEL) Shares Sold by Lisanti Capital Growth LLCLisanti Capital Growth LLC lowered its stake in Vericel Co. (NASDAQ:VCEL - Free Report) by 51.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,430 shares of the biotechnology company's stock after selling 27,015 sharMarch 8, 2025 | marketbeat.comProficio Capital Partners LLC Buys New Shares in Vericel Co. (NASDAQ:VCEL)Proficio Capital Partners LLC bought a new stake in Vericel Co. (NASDAQ:VCEL - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 17,406 shares of the biotechnology company's stock, valued at approximately $956,000.March 8, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Upgraded by StockNews.com to "Hold" RatingStockNews.com upgraded Vericel from a "sell" rating to a "hold" rating in a research note on Saturday.March 8, 2025 | marketbeat.comVericel: Scalable Growth With Strong MarginsMarch 6, 2025 | seekingalpha.comFisher Asset Management LLC Grows Position in Vericel Co. (NASDAQ:VCEL)Fisher Asset Management LLC grew its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 170,500 shares of the biotechnology company's stock after acquMarch 5, 2025 | marketbeat.comVericel to Present at Multiple Upcoming Investor ConferencesMarch 4, 2025 | globenewswire.comVericel's (VCEL) "Buy" Rating Reiterated at Truist FinancialTruist Financial reissued a "buy" rating and issued a $61.00 price target (down from $67.00) on shares of Vericel in a research note on Monday.March 3, 2025 | marketbeat.comVericel Co. (NASDAQ:VCEL) Shares Purchased by Mutual of America Capital Management LLCMutual of America Capital Management LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 13.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 150,141 shares of the biotechnology company's stock after buying anMarch 3, 2025 | marketbeat.comFY2025 EPS Estimates for Vericel Lowered by HC WainwrightVericel Co. (NASDAQ:VCEL - Free Report) - Equities researchers at HC Wainwright reduced their FY2025 earnings per share estimates for shares of Vericel in a note issued to investors on Friday, February 28th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post eMarch 3, 2025 | marketbeat.comQ2 Earnings Forecast for Vericel Issued By Leerink PartnrsVericel Co. (NASDAQ:VCEL - Free Report) - Stock analysts at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of Vericel in a report issued on Thursday, February 27th. Leerink Partnrs analyst M. Kratky now anticipates that the biotechnology company will post earnings pMarch 3, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Downgraded by StockNews.com to "Sell"StockNews.com lowered shares of Vericel from a "hold" rating to a "sell" rating in a report on Friday.March 1, 2025 | marketbeat.comEarnings call transcript: Vericel Corp Q4 2024 reports strong growthMarch 1, 2025 | uk.investing.comHC Wainwright Reaffirms Buy Rating for Vericel (NASDAQ:VCEL)HC Wainwright reaffirmed a "buy" rating and issued a $60.00 price target on shares of Vericel in a research note on Friday.March 1, 2025 | marketbeat.comGW&K Investment Management LLC Raises Holdings in Vericel Co. (NASDAQ:VCEL)GW&K Investment Management LLC raised its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,273,964 shares of the biotechnology companMarch 1, 2025 | marketbeat.comTruist Financial Remains a Buy on Vericel (VCEL)March 1, 2025 | markets.businessinsider.comVericel (NASDAQ:VCEL) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPSVericel (NASDAQ:VCEL - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.07. Vericel had a return on equity of 1.48% and a net margin of 1.56%.February 28, 2025 | marketbeat.comQ4 2024 Vericel Corp Earnings CallFebruary 28, 2025 | uk.finance.yahoo.comVericel Corp (VCEL) Q4 2024 Earnings Call Highlights: Record Revenue and Strong Growth TrajectoryFebruary 28, 2025 | finance.yahoo.comAnalysts Are Bullish on Top Healthcare Stocks: Vericel (VCEL), Astria Therapeutics (ATXS)February 27, 2025 | markets.businessinsider.comVericel Corporation (VCEL) Q4 2024 Earnings Conference Call TranscriptFebruary 27, 2025 | seekingalpha.comVericel Corporation 2024 Q4 - Results - Earnings Call PresentationFebruary 27, 2025 | seekingalpha.comVericel Reports Fourth Quarter and Full-Year 2024 Financial ResultsFebruary 27, 2025 | globenewswire.comVericel Co. (NASDAQ:VCEL) Given Consensus Recommendation of "Buy" by AnalystsShares of Vericel Co. (NASDAQ:VCEL - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokeraFebruary 27, 2025 | marketbeat.comPrincipal Financial Group Inc. Boosts Stake in Vericel Co. (NASDAQ:VCEL)Principal Financial Group Inc. grew its stake in Vericel Co. (NASDAQ:VCEL - Free Report) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 262,932 shares of the biotechnology company's stock after bFebruary 27, 2025 | marketbeat.comVericel (VCEL) to Release Earnings on ThursdayVericel (NASDAQ:VCEL) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666287)February 21, 2025 | marketbeat.comNew York State Common Retirement Fund Has $46.94 Million Stock Holdings in Vericel Co. (NASDAQ:VCEL)New York State Common Retirement Fund decreased its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 854,902 shares of the biotechnology coFebruary 20, 2025 | marketbeat.comKornitzer Capital Management Inc. KS Purchases Shares of 12,000 Vericel Co. (NASDAQ:VCEL)Kornitzer Capital Management Inc. KS purchased a new stake in Vericel Co. (NASDAQ:VCEL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,000 shares of the biotechnology company's stock, valued at approximaFebruary 20, 2025 | marketbeat.comTimesSquare Capital Management LLC Acquires 42,015 Shares of Vericel Co. (NASDAQ:VCEL)TimesSquare Capital Management LLC increased its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 632,160 shares of the biotechnology company's stoFebruary 19, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Cuts Stock Holdings in Vericel Co. (NASDAQ:VCEL)Allspring Global Investments Holdings LLC lowered its stake in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 35.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 261,073 shares of the biotechnoloFebruary 18, 2025 | marketbeat.comCongress Asset Management Co. Grows Stock Holdings in Vericel Co. (NASDAQ:VCEL)Congress Asset Management Co. grew its holdings in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,454,139 shares of the biotechnology company's stocFebruary 16, 2025 | marketbeat.comLegato Capital Management LLC Sells 8,144 Shares of Vericel Co. (NASDAQ:VCEL)Legato Capital Management LLC reduced its holdings in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 58.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,720 shares of the biotechnology company's stocFebruary 15, 2025 | marketbeat.comVericel director Kevin McLaughlin sells shares worth $388,250February 14, 2025 | msn.comVericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025February 13, 2025 | globenewswire.comVericel's principal accounting officer sells $67,693 in stockFebruary 8, 2025 | msn.comVericel director Robert Zerbe sells $156,250 in stockFebruary 8, 2025 | msn.comVericel Co. (NASDAQ:VCEL) Insider Sells $67,693.08 in StockFebruary 8, 2025 | insidertrades.comVericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 SharesVericel Co. (NASDAQ:VCEL - Get Free Report) insider Jonathan Siegal sold 1,092 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $61.99, for a total value of $67,693.08. Following the completion of the transaction, the insider now directly owns 1,206 shares in the company, valued at $74,759.94. This trade represents a 47.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.February 7, 2025 | marketbeat.comRobert L. Md Zerbe Sells 2,500 Shares of Vericel Co. (NASDAQ:VCEL) StockVericel Co. (NASDAQ:VCEL - Get Free Report) Director Robert L. Md Zerbe sold 2,500 shares of the stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $62.50, for a total value of $156,250.00. Following the sale, the director now directly owns 26,595 shares in the company, valued at $1,662,187.50. This trade represents a 8.59 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.February 7, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Hits New 52-Week High - Still a Buy?Vericel (NASDAQ:VCEL) Sets New 1-Year High - Here's WhyFebruary 5, 2025 | marketbeat.comVericel price target raised to $67 from $64 at CanaccordFebruary 4, 2025 | markets.businessinsider.comConestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL)Conestoga Capital Advisors LLC trimmed its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 0.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,069,430 shares of the biotechnology company's stock aftFebruary 3, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Price Target Raised to $67.00 at Canaccord Genuity GroupCanaccord Genuity Group boosted their price target on shares of Vericel from $64.00 to $67.00 and gave the company a "buy" rating in a report on Monday.February 3, 2025 | marketbeat.comVericel Co. (NASDAQ:VCEL) Receives Consensus Rating of "Buy" from BrokeragesShares of Vericel Co. (NASDAQ:VCEL - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are currently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-monthFebruary 2, 2025 | marketbeat.comSG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL)SG Americas Securities LLC lessened its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 60.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 9,706 shares of the biotechnology company's stock after selling 14,780 shares during the peFebruary 1, 2025 | marketbeat.comJonathan Siegal Sells 3,908 Shares of Vericel Co. (NASDAQ:VCEL) StockJanuary 31, 2025 | insidertrades.com Remove Ads Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address VCEL Media Mentions By Week VCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCEL News Sentiment▼0.950.78▲Average Medical News Sentiment VCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCEL Articles This Week▼55▲VCEL Articles Average Week Remove Ads Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRPT News Today PCVX News Today QGEN News Today ASND News Today ROIV News Today LNTH News Today RVMD News Today LEGN News Today TGTX News Today TLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCEL) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
